Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700194 | Clinical Oncology | 2006 | 8 Pages |
Abstract
Weekly cisplatin 40Â mg/m2 concurrent with radiotherapy is well tolerated when given to an unselected population of patients. Survival rates seem to be excellent, with both local control and overall survival being at least as good as those in published randomised trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. King, C. McConkey, T.N. Latief, A. Hartley, I. Fernando,